|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of anaphylaxis; Pharmaceutical preparations for the... |
|
|
P/S
|
pharmaceutical preparations exhibiting vasoconstricting, intraocular pressure-reducing, and bronc... |
|
|
P/S
|
Pharmaceutical preparations for treating anaphylaxis; pharmaceutical preparations exhibiting vaso... |
|
2024
|
Invention
|
Benzimidazole derivatives compositions.
The present disclosure relates to compositions including... |
|
|
Invention
|
Liquid dalbavancin compositions.
The present disclosure relates to a stable aqueous composition ... |
|
|
Invention
|
Daptomycin formulations.
The present invention relates to compositions comprising daptomycin and... |
|
|
Invention
|
Stable micafungin compositions. A stable liquid composition suitable for intravenous administrati... |
|
|
Invention
|
Ready-to-administer hydromorphone formulations.
The present disclosure relates to a ready-to-adm... |
|
|
Invention
|
Pharmaceutical compositions of tofacitinib for oral administration.
Liquid pharmaceutical compos... |
|
|
Invention
|
Liquid composition comprising glucose. The present disclosure relates to an aqueous composition s... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of bone disease, oncological and metabolic diseases... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of bone
disease, oncological and metabolic disease... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of hypotension; pharmaceutical preparation in the n... |
|
|
Invention
|
Hydromorphone formulations for multi-dose products. The present disclosure relates to a multi-dos... |
|
2023
|
Invention
|
Oxytocin formulation.
The present disclosure relates to a ready-to-administer formulation of oxy... |
|
|
Invention
|
Buffered lidocaine injectable formulations and methods for making same. A stable liquid formulati... |
|
|
Invention
|
Buffered lidocaine injectable formulations and methods for making same.
A stable liquid formulat... |
|
|
Invention
|
Liquid dalbavancin compositions. The present disclosure relates to a stable aqueous composition o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparation... |
|
|
Invention
|
Epinephrine spray formulations.
The present invention is directed to epinephrine spray formulati... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune disorders, excluding chronic hand ecz... |
|
|
Invention
|
Pharmaceutical compositions of tofacitinib for oral administration. Liquid pharmaceutical composi... |
|
|
P/S
|
Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hosp... |
|
|
Invention
|
Daptomycin formulations. The present invention relates to compositions comprising daptomycin and ... |
|
|
Invention
|
Ready-to-administer product comprising a norepinephrine formulation |
|
|
Invention
|
Injectable phenylephrine compositions |
|
|
Invention
|
Oxytocin formulation |
|
|
Invention
|
Rocuronium bromide prefilled syringe. Prefilled syringes containing a rocuronium bromide solution... |
|
|
Invention
|
Liquid naloxone spray.
The invention provides stable liquid formulations containing naloxone, a ... |
|
|
Invention
|
Hydromorphone formulations for multi-dose products.
The present disclosure relates to a multi-do... |
|
|
Invention
|
Glycopeptide compositions. Solutions comprising a glycopeptide antibiotic, for example Vancomycin... |
|
2022
|
Invention
|
Tofacitinib extended release formulations.
Sustained release pharmaceutical dosage forms include... |
|
|
Invention
|
Stable, ready-to-administer aqueous formulations of dalbavancin. An aqueous pharmaceutical compos... |
|
|
Invention
|
Phenylephrine hydrochloride ready-to-use solution. This invention relates to a dilute, ready-to-u... |
|
|
Invention
|
Rocuronium bromide prefilled syringe.
Prefilled syringes containing a rocuronium bromide solutio... |
|
|
Invention
|
Ready-to-administer hydromorphone formulations. The present disclosure relates to a ready -to-adm... |
|
|
Invention
|
Ready-to-administer hydromorphone formulations. The present disclosure relates to a ready-to-admi... |
|
|
P/S
|
providing grants for projects related to drug safety, addiction and recovery |
|
2021
|
P/S
|
On-line retail store services featuring pharmaceutical products; On-line wholesale store services... |
|
|
Invention
|
Ready-to-administer fentanyl formulations. The stable liquid formulations for parenteral administ... |
|
|
P/S
|
Custom manufacture of pharmaceutical preparations and substances for others. |
|
|
P/S
|
Pharmaceutical, medicinal, and veterinary preparations and
substances, namely, systemic anti-inf... |
|
|
Invention
|
Succinylcholine chloride prefilled syringe. Prefilled syringes containing a succinylcholine chlor... |
|
|
Invention
|
Succinylcholine chloride prefilled syringe.
Prefilled syringes containing a succinylcholine chlo... |
|
|
Invention
|
Liquid naloxone spray. The invention provides stable liquid formulations containing naloxone, a p... |
|
|
Invention
|
Methods of stabilizing epinephrine. The present invention is directed to methods of stabilizing a... |
|
|
Invention
|
Oral dosage forms of ibrutinib. Stable and bioavailable oral dosage forms of ibrutinib, the dosag... |
|
|
P/S
|
Pharmaceutical preparations for use as a narcotic antagonist
in treatment of opioid overdose. |
|
|
P/S
|
Pharmaceutical preparations for use as a narcotic antagonist in treatment of opioid overdose. |
|
|
Invention
|
System and method for purging oxygen from medical vials.
A medical vial filling system is adapte... |
|
|
P/S
|
Custom manufacture of pharmaceutical preparations and substances for others |
|
|
Invention
|
Pharmaceutical compositions of tofacitinib for oral administration. The present invention relates... |
|
|
Invention
|
Epinephrine spray formulations. The present invention is directed to epinephrine spray formulatio... |
|
|
Invention
|
Daptomycin formulation.
The present disclosure relates to a solid formulation of daptomycin comp... |
|
2020
|
P/S
|
Phenylephrine pharmaceutical preparations for use as a vasoconstrictor, regulating blood pressure... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for use as a narcotic antagonist in treatment of opioid overdose |
|
|
P/S
|
Pharmaceutical preparations for use as a narcotic antagonist in treatment of opioid overdose |
|
|
Invention
|
Vasopressin liquid formulations. A liquid pharmaceutical composition for intravenous administrati... |
|
|
Invention
|
Daptomycin aqueous formulations.
The present disclosure is related to providing a stable daptomy... |
